FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891382652> ?p ?o ?g. }

• W2891382652 endingPage "276" @default.
• W2891382652 startingPage "263" @default.
• W2891382652 abstract "Abstract Although androgen deprivation therapy (ADT) is an effective treatment for metastatic prostate cancer, incurable castration-resistant prostate cancer (CRPC) inevitably develops. Importantly, androgen receptor (AR) continues to be critical for prostate cancer growth and progression after ADT. One of the underlying molecular mechanisms is derepression of AR-repressed genes involved in cell cycle and proliferation after ADT. Here, the data demonstrate that C-X-C chemokine receptor type 7 (CXCR7), a seven-transmembrane G-protein–coupled chemokine receptor, is an AR-repressed gene and is upregulated after ADT. AR directly regulates CXCR7 using clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) gene editing. Macrophage migration inhibitory factor (MIF) was identified as a ligand for CXCR7, which induces expression of cell-cycle genes through activating AKT signaling pathway. Previous studies have been focused on chemokine CXCL12 and its receptor CXCR4 in mediating metastasis of various cancer types, including prostate cancer. The critical roles of CXCL12/CXCR4 axis in the interaction between cancer cells and their microenvironment render it a promising therapeutic target in cancer treatment. The data suggest that the MIF/CXCR7/AKT pathway drives CRPC growth and metastasis independent of the CXCL12/CXCR4 axis. Furthermore, CXCR7 blockade in combination with anti-androgen enzalutamide inhibits CRPC tumor growth and potentially prevents metastasis. Notably, both MIF and CXCR7 are overexpressed in CRPC patient specimens and therefore are attractive therapeutic targets for these patients. Implications: This work suggests that CXCR7 plays more important roles than CXCR4 in CRPC progression; thus, targeting CXCR7 in combination with anti-androgen is a promising therapeutic approach for metastatic CRPC." @default.
• W2891382652 created "2018-09-27" @default.
• W2891382652 creator A5025970058 @default.
• W2891382652 creator A5043310242 @default.
• W2891382652 creator A5046265881 @default.
• W2891382652 creator A5056908913 @default.
• W2891382652 creator A5072104844 @default.
• W2891382652 creator A5085043234 @default.
• W2891382652 date "2019-01-01" @default.
• W2891382652 modified "2023-09-27" @default.
• W2891382652 title "Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer" @default.
• W2891382652 cites W1860918802 @default.
• W2891382652 cites W1879165674 @default.
• W2891382652 cites W1890667195 @default.
• W2891382652 cites W1919512980 @default.
• W2891382652 cites W1968542980 @default.
• W2891382652 cites W1969594138 @default.
• W2891382652 cites W1973442219 @default.
• W2891382652 cites W1975053308 @default.
• W2891382652 cites W1990149668 @default.
• W2891382652 cites W2000672459 @default.
• W2891382652 cites W2027075319 @default.
• W2891382652 cites W2035832696 @default.
• W2891382652 cites W2036176224 @default.
• W2891382652 cites W2041034966 @default.
• W2891382652 cites W2053116646 @default.
• W2891382652 cites W2073100248 @default.
• W2891382652 cites W2097065948 @default.
• W2891382652 cites W2103506867 @default.
• W2891382652 cites W2106070783 @default.
• W2891382652 cites W2107633226 @default.
• W2891382652 cites W2114104545 @default.
• W2891382652 cites W2118428599 @default.
• W2891382652 cites W2121548063 @default.
• W2891382652 cites W2123792735 @default.
• W2891382652 cites W2124664018 @default.
• W2891382652 cites W2125935825 @default.
• W2891382652 cites W2128316913 @default.
• W2891382652 cites W2131836848 @default.
• W2891382652 cites W2131848867 @default.
• W2891382652 cites W2134526812 @default.
• W2891382652 cites W2141077390 @default.
• W2891382652 cites W2145137051 @default.
• W2891382652 cites W2147900600 @default.
• W2891382652 cites W2153044787 @default.
• W2891382652 cites W2156140889 @default.
• W2891382652 cites W2156323704 @default.
• W2891382652 cites W2158217645 @default.
• W2891382652 cites W2160975559 @default.
• W2891382652 cites W2161112598 @default.
• W2891382652 cites W2431032595 @default.
• W2891382652 cites W2517270366 @default.
• W2891382652 cites W2535696208 @default.
• W2891382652 cites W2560832549 @default.
• W2891382652 cites W2621319673 @default.
• W2891382652 cites W2726649836 @default.
• W2891382652 cites W2778263691 @default.
• W2891382652 cites W2781525129 @default.
• W2891382652 doi "https://doi.org/10.1158/1541-7786.mcr-18-0412" @default.
• W2891382652 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6318022" @default.
• W2891382652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30224544" @default.
• W2891382652 hasPublicationYear "2019" @default.
• W2891382652 type Work @default.
• W2891382652 sameAs 2891382652 @default.
• W2891382652 citedByCount "25" @default.
• W2891382652 countsByYear W28913826522019 @default.
• W2891382652 countsByYear W28913826522020 @default.
• W2891382652 countsByYear W28913826522021 @default.
• W2891382652 countsByYear W28913826522022 @default.
• W2891382652 countsByYear W28913826522023 @default.
• W2891382652 crossrefType "journal-article" @default.
• W2891382652 hasAuthorship W2891382652A5025970058 @default.
• W2891382652 hasAuthorship W2891382652A5043310242 @default.
• W2891382652 hasAuthorship W2891382652A5046265881 @default.
• W2891382652 hasAuthorship W2891382652A5056908913 @default.
• W2891382652 hasAuthorship W2891382652A5072104844 @default.
• W2891382652 hasAuthorship W2891382652A5085043234 @default.
• W2891382652 hasBestOaLocation W28913826521 @default.
• W2891382652 hasConcept C121608353 @default.
• W2891382652 hasConcept C126322002 @default.
• W2891382652 hasConcept C129470790 @default.
• W2891382652 hasConcept C13373296 @default.
• W2891382652 hasConcept C170493617 @default.
• W2891382652 hasConcept C2776107976 @default.
• W2891382652 hasConcept C2776551883 @default.
• W2891382652 hasConcept C2777899217 @default.
• W2891382652 hasConcept C2779013556 @default.
• W2891382652 hasConcept C2780192828 @default.
• W2891382652 hasConcept C3020616263 @default.
• W2891382652 hasConcept C502942594 @default.
• W2891382652 hasConcept C61367390 @default.
• W2891382652 hasConcept C62478195 @default.
• W2891382652 hasConcept C71924100 @default.
• W2891382652 hasConcept C75217442 @default.
• W2891382652 hasConcept C86554907 @default.
• W2891382652 hasConcept C86803240 @default.
• W2891382652 hasConcept C95444343 @default.
• W2891382652 hasConceptScore W2891382652C121608353 @default.

• next